IvyCap Ventures led the pre-Series A funding round for the health tech company FlexifyMe, which raised Rs 20 crore ($2.4 million) with the help of Signal Ventures and previous investors.
Before, the business raised $1 million in a seed funding round headed by Flipkart Ventures. It also appeared on Shark Tank India Season 3, where Namita Thapar (Emcure) invested.
According to a press release from FlexifyMe, the new funding will be used to strengthen clinical research collaborations, establish advanced posture and gait analysis labs, and expedite the company’s hybrid care expansion (online and offline centers).
FlexifyMe, which was co-founded in 2021 by Manjeet Singh and Amit Bhayani, uses professional physiotherapy in conjunction with AI-driven posture and motion analysis to pinpoint the underlying causes of persistent musculoskeletal pain. The company helps cut down on needless procedures and enhance long-term patient outcomes by switching from subjective, symptom-based care to data-driven, trackable interventions.
“By combining technology, licensed physiotherapists and rigorous progress tracking, we are making the journey to a pain-free life scientific, objective and measurable. This funding allows us to scale these capabilities so millions can avoid unnecessary surgeries, return to the activities they love, and regain meaningful quality of life,” said Manjeet Singh, co-founder, FlexifyMe.
Using a combination of traditional knowledge and state-of-the-art technology, the Pune-based platform offers guided video sessions, personalized programs, and live one-on-one sessions with certified instructors.
According to FlexifyMe, thousands of users in India and other international markets already trust it. It provides clinically validated results by collaborating with businesses, insurers, and healthcare ecosystems.
